What We're Reading: Page 352
Industry reads hand-picked by our editors
Nov 19, 2015
Nov 18, 2015
-
PharmaLive
How Vertex's long-term $500k gamble paid off with a $30 billion return
-
Stat
Companies seek to diagnose cancer from a blood sample
-
Reuters
Top healthcare stock fund focuses on costs, orphan drugs in 2016
-
Stat
Medicaid group ramps up lobbying on drug prices
-
None
Liver Meeting '15: AASLD calls out payers on HCV med coverage; WHO's plan to wipe out hep C & B by 2030
Previous
